Felodipine Hair Loss: Risk, Timeline & Fixes

byTOUATI -

Felodipine hair loss is best approached with timeline logic, because most medication-linked shedding behaves like telogen effluvium (TE): the trigger happens first, and increased shedding becomes noticeable later. For felodipine, a calcium channel blocker (CCB), the current evidence is more nuanced than a simple “yes” or “no.” Current felodipine extended-release labeling does not clearly list alopecia as a common or named dermatologic adverse event. Instead, the main adverse-reaction picture is dominated by peripheral edema and headache, with other lower-frequency effects such as dizziness, rash, and flushing. That means suspected shedding on felodipine is usually best interpreted through timing + pattern + competing triggers, rather than through a strong molecule-level alopecia label signal.

Medical note: This article is for general education and does not provide personal medical advice. Do not stop or change felodipine without clinician guidance. If you are not sure whether you are seeing shedding or breakage, start here: Shedding vs Breakage. If the diagnosis is unclear, start here: How Hair Loss Is Diagnosed. If you have scalp pain/burning, pustules/crusting, heavy scale, open sores, or rapid worsening, start here: When to See a Doctor.

Felodipine hair loss: calcium channel blocker shedding, telogen effluvium timing, diffuse pattern clues, labs, and practical next steps.
Suspected felodipine-related shedding is usually best interpreted through delayed telogen effluvium timing and a diffuse pattern rather than a sudden one-week cause.

Quick navigation

Key takeaways

What the product information says / what it doesn’t

What the current label does say: current felodipine extended-release labeling emphasizes peripheral edema and headache as the most common clinical adverse events at recommended doses. Peripheral edema was generally mild but dose- and age-related, and the label notes that it often occurs within the first few weeks of treatment rather than months later.

What appears in the controlled-trial table: adverse events occurring in 1.5% or greater at recommended doses included peripheral edema, headache, warm sensation, palpitations, nausea, dyspepsia, constipation, dizziness, upper respiratory infection, cough, rhinorrhea, sneezing, rash, and flushing.

What it does not clearly show: in the current labeling reviewed for this article, alopecia is not clearly listed as a common named adverse effect or a direct molecule-level signal.

What is still relevant: the same labeling includes less common skin findings such as angioedema, erythema, urticaria, and leukocytoclastic vasculitis. These matter clinically, but they are not the same as proving medication-triggered hair shedding.

Practical interpretation: if someone develops diffuse shedding while taking felodipine, the useful next step is not to assume causation from the drug name alone. The real question is whether the timeline fits TE, whether the pattern is diffuse, and whether there were other triggers in the same 2–4 month window.

Timeline: onset, peak, recovery

For most practical suspected medication-shedding cases, the most useful model is telogen effluvium.

  • Onset: the key clue is delay. Hair fall is often noticed about 2–4 months after a trigger and can occur around 3 months after a trigger.
  • Peak: once shedding starts, it may feel worst for several weeks.
  • Recovery: once the trigger is addressed or stabilizes, shedding usually slows first; visible density recovery takes longer.
  • Duration clue: acute TE shedding often lasts about 3–6 months, but cosmetic regrowth usually takes longer.

This delay is why people often miss the connection. Someone may start felodipine, feel stable for weeks, and only later notice more hair in the shower, on the pillow, or on the brush. That pattern fits hair-cycle timing much better than a dramatic same-week reaction.

Useful nuance: if ankle swelling or flushing appeared early but shedding only showed up much later, that does not rule out a medication contribution—but it does remind you that different adverse effects can follow very different timelines.

Pattern clues: TE vs AGA vs AA vs breakage

Most consistent with TE

Medication-linked TE usually looks like diffuse shedding with a generally normal-looking scalp. You notice more hair fall all over, not one sharply defined bald patch.

TE + androgenetic alopecia overlap

If shedding improves but the part line keeps widening or the crown continues to thin, think about overlap with telogen effluvium vs androgenetic alopecia.

Alopecia areata is a different pattern

If you have patchy, smooth, well-defined bald areas, that is less typical for medication-triggered TE and should raise the question of alopecia areata.

Breakage is not the same as shedding

If you mostly see short snapped hairs, rough texture, or frayed ends, that points more toward hair breakage than true root-level shedding.

If the scalp is inflamed, think broader than TE

TE is usually a non-scarring diffuse shedding pattern without obvious inflammation. If the scalp is very itchy, red, painful, blistered, crusted, or visibly irritated, a simple TE explanation becomes less complete and you should review for another scalp disorder, another drug reaction, or a different diagnosis.

When labs matter

Not every patient with a plausible medication timeline needs a broad lab panel. But labs matter more when shedding is heavy, persistent, recurrent, or the history suggests overlap causes such as iron deficiency, thyroid disease, major weight change, illness, dietary restriction, or another systemic stressor in the same window.

For the site workup roadmap, use: Blood Tests & Workup.

What to do (practical plan)

  1. Build the timeline: write down the felodipine start date, any dose changes, and the month shedding became noticeable.
  2. Confirm the pattern: diffuse shedding vs breakage vs overlap pattern hair loss vs patchy loss.
  3. Review stacked triggers: illness, fever, surgery, postpartum timing, dieting, weight loss, thyroid issues, low iron, or major stress in the same 2–4 month window.
  4. Look for skin clues: rash, hives, swelling, or other skin symptoms that point to a different kind of reaction than quiet TE-type shedding.
  5. Talk to the prescriber: if timing fits, discuss blood pressure treatment context and whether any alternative is reasonable. Do not self-stop.
  6. Avoid supplement roulette: add supplements only when history, labs, or clinician guidance supports a deficiency.
  7. Track monthly: use photos every 4 weeks in the same lighting and angle so you can judge trend, not day-to-day anxiety.

When to see a doctor

  • Scalp pain, burning, pustules, open sores, blistering, or heavy scale/crusting
  • Patchy smooth bald spots rather than diffuse shedding
  • Obvious eyebrow or eyelash involvement
  • Facial swelling, hives, or other possible medication-reaction symptoms
  • Shedding that persists beyond about 6 months or returns in repeated waves
  • Unclear diagnosis or rapid worsening

Start here: When to See a Doctor.

FAQ

Does the current felodipine label clearly list alopecia?

No. In the current extended-release labeling reviewed for this page, alopecia is not clearly listed as a named common adverse effect.

Does that mean felodipine cannot be related to shedding?

No. It means the current direct label support is weaker than for some other calcium channel blockers. Individual evaluation still depends on timing, pattern, and whether there were other triggers in the same window.

Why does shedding start months later?

Because TE is delayed. The trigger shifts more hairs into the resting phase first, and the increased shedding becomes noticeable later.

Is felodipine hair loss permanent?

When the pattern behaves like telogen effluvium, it is usually non-scarring and reversible once the trigger stabilizes, but regrowth takes time.

Should I stop felodipine if I suspect shedding?

No. Do not stop it on your own. The safer next step is to review the timeline and treatment context with the prescriber first.

References (trusted sources)

Last updated: March 14, 2026.

Tags:
Previous Post Next Post
Share to other apps
Copy Post Link

Contact Form